SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Silk Road Medical, Inc (SILK) .
本页证实的标准:
- VALUE (60/100, 通过) — 分析师目标价暗示上行空间 (+11.2%).
- 分析师共识目标价 $30.58 (+11.2% 上行空间) — 预期温和上涨。
SharesGrow 综合评分： 41/100 其中 1/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
60/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SILK
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率6.02
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.44
每股账面价值$0.00
每股营收$4.56
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$30.58 (+11.2%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2017 |
$-0.80 |
$14.26M |
$-19.36M |
-135.8% |
| 2018 |
$-1.31 |
$34.56M |
$-37.63M |
-108.9% |
| 2019 |
$-2.44 |
$63.35M |
$-56.07M |
-88.5% |
| 2020 |
$-1.53 |
$75.23M |
$-50.39M |
-67% |
| 2021 |
$-1.45 |
$101.48M |
$-50.39M |
-49.7% |
| 2022 |
$-1.62 |
$138.64M |
$-58.02M |
-41.8% |
| 2023 |
$-1.44 |
$177.13M |
$-55.74M |
-31.5% |
